Principal Securities, Inc. Cure Vac N.V. Transaction History
Principal Securities, Inc.
- $4.44 Trillion
- Q4 2024
A detailed history of Principal Securities, Inc. transactions in Cure Vac N.V. stock. As of the latest transaction made, Principal Securities, Inc. holds 291 shares of CVAC stock, worth $1,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
291
Previous 291
-0.0%
Holding current value
$1,062
Previous $856,000
15.89%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CVAC
# of Institutions
86Shares Held
12.6MCall Options Held
68.1KPut Options Held
55.7K-
Black Rock Inc. New York, NY2.25MShares$8.23 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$6.01 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.73 Million10.6% of portfolio
-
Ubs Group Ag577KShares$2.11 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$1.83 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $684M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...